Description
An oxazolidinone antibiotic; is active against a wide range of Gram-positive bacterial clinical isolates (MICs = 0.125-4 μg/ml); increases survival in mouse models of systemic MRSA, E. faecalis, S. pneumoniae, and H. influenzae infection (ED50s = 2.96, 4.53, 2.28, and 9.96 mg/kg, respectively)
Formal name: (5R)-3-[4-(5,6-dihydro-1-methyl-1,2,4-triazin-4(1H)-yl)-3-fluorophenyl]-5-(hydroxymethyl)-2-oxazolidinone
Synonyms: LCB01-0371
Molecular weight: 308.3
CAS: 1219707-39-7
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antibiotics|Oxazolidinones||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Bacterial Diseases|MRSA||Research Area|Infectious Disease|Bacterial Diseases|Pneumonia